← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 19, 2017Last known activity
Oct 19, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 7 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT05023707CollaboratorPhase 1/Phase 2Oct 19, 2021
- NCT04846439CollaboratorPhase 1/Phase 2Apr 29, 2021
- NCT05021276CollaboratorPhase 4Dec 15, 2020
- NCT04313335CollaboratorN/AAug 1, 2020
- NCT04087967CollaboratorPhase 3Apr 1, 2019
- NCT03600831CollaboratorPhase 2/Phase 3Aug 20, 2018
- NCT04287660CollaboratorPhase 3Oct 19, 2017
Details
- Last known activity
- Oct 19, 2021